Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women.
about
Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significanceAspirin and risk of multiple myeloma in adults: A systematic review and meta-analysis.Malignancy in systemic lupus erythematosus: what have we learned?Medication use and multiple myeloma risk in Los Angeles County.Variation in innate immunity genes and risk of multiple myelomaRisk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies.Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era.Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studiesUse of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies.Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.Statins and the risk of gastric cancer in diabetes patients.Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink.Antithyroid drugs induced agranulocytosis and multiple myeloma: case report and general considerationsUse of hair colouring products and risk of multiple myeloma among US women.Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses' health study.Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis.Statin use and risk of multiple myeloma: An analysis from the cancer research network.Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC).Menopausal estrogen therapy and non-Hodgkin's lymphoma: A post-hoc analysis of women's health initiative randomized clinical trial.Use of benzodiazepine and risk of cancer: A meta-analysis of observational studies.Risk of multiple myeloma in a case-spouse study.Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma.Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort.Benzodiazepine drug use and cancer risk: a dose-response meta analysis of prospective cohort studies.Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.Associations of common variants in genes involved in metabolism and response to exogenous chemicals with risk of multiple myeloma.
P2860
Q26743454-D1E3E682-2122-4DDA-86CD-4D2015465BBCQ30841754-DA40C8B8-5F4F-48F9-A850-6F3E8EA13FEBQ34087859-5CABF589-E4E2-4578-B498-02BFA54FD792Q34145450-A71C943F-1683-4521-B7CD-8E871EB8D5E6Q34306330-BBD54312-CF79-4BC2-B300-679931145C70Q35120199-2C69C3D9-3D15-4CEA-8D47-0F91E28CB8D8Q35439366-5C11B5E4-BEDD-469A-BF3B-57AA37CBD455Q35602162-218B9841-D58D-483F-9E4A-B6071DF51AE1Q36024705-DDCC3D23-A2E7-47D9-B6B2-17E51F71ABA3Q36508844-491830ED-7EED-4F4D-A9B5-E14C72557037Q36521575-0D383961-A509-40CF-81E6-D2B351920655Q36609598-3E1AA42C-F446-48D3-9AD4-2F2BE01447C3Q37249592-BA2670E2-CFE5-4733-B381-E0BB58D423EEQ37373103-23D7FF1A-9454-4491-8E2C-6ACB45D8D493Q37507892-E0A5535D-FE61-40BF-9F98-75EFBC877E46Q37538571-75883C9A-9E92-4185-A95E-F67D8DA7DF36Q38692861-07FFF3B8-A50C-4062-90B0-813FFFBFBC43Q40323003-B6F7CAFE-A9A4-4C10-8E48-F922F1CD4236Q40544175-25AF7E59-FA8A-478A-885F-D933274EAB88Q40566145-D2600C5E-6514-42EA-836B-B5B82A73A5E9Q41284957-F417DAC0-CB4A-4052-A469-F3FF31E5A533Q45866054-F1E117CE-8804-4BF9-85AB-2980BFE42E78Q46463027-D9042693-4E33-4681-B959-E28EA02A404AQ47140702-2C4495DD-30DD-42A9-87C9-4064DB03CCDBQ52860687-75BB1A52-FFDA-42DE-BC8B-E55AC8A14F32Q54965252-199C7E05-42AA-40DF-9864-4ABADE98A25C
P2860
Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Risk of multiple myeloma follo ...... ol study in Connecticut women.
@en
type
label
Risk of multiple myeloma follo ...... ol study in Connecticut women.
@en
prefLabel
Risk of multiple myeloma follo ...... ol study in Connecticut women.
@en
P2093
P1476
Risk of multiple myeloma follo ...... ol study in Connecticut women.
@en
P2093
Dalsu Baris
Peter Inskip
Sheila Hoar Zahm
Tongzhang Zheng
Yawei Zhang
P304
P356
10.1158/1055-9965.EPI-06-0097
P50
P577
2006-11-28T00:00:00Z